Akèy › Metiyè › Molecular and Cellular Biologists › Pasadena, CA
Molecular and Cellular Biologists nan Pasadena, CA: Salè H-1B
76 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Pasadena, CA. Salè baz medyàn ofri $72,000; mwatye mitan $66,916–$75,000.
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $70,990 |
| Nivo II (kalifye) | $72,480 |
| Nivo III (eksperyans) | $107,203 |
| Nivo IV (plen kompetans) | $125,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| California Institute of Technology | 65 | $71,000 |
| Howard Hughes Medical Institute | 4 | $73,182 |
| Xencor, Inc. | 2 | $125,000 |
| AcuraStem Incorporated | 2 | $86,102 |
| Lawrence Berkeley National Laboratory | 1 | $100,812 |
| University of Mississippi | 1 | $70,990 |
| ProteinSimple | 1 | $82,493 |
Tit travay
- Postdoctoral Scholar Research Associate in BBE11
- Senior Postdoctoral Scholar Research Associate in BBE10
- Staff Scientist6
- Postdoctoral Scholar Research Assoc. in Bbe6
- Research Scientist6
- Postdoc Scholar Research Associate Biology & Biological Eng2
- Postdoctoral Scholar in Biology & Biological Engineering2
- Director, Stem Cell and Embryo Engineering Center2
- Sr. Scientist2
- Postdoctoral Scientist2
- Postdoctoral Scholar Research Associate in Biology & Bio Eng1
- Postdoctoral Scholar in Neuroscience1
- Postdoctoral Scholar in Biology and Biological Engineering1
- Computational Biologist Project Scientist1
- Senior Postdoctoral Scholar in Neuroscience1
Pwonse H-1B nan Pasadena, CA →
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).